These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34983996)

  • 1. Brolucizumab: Evaluation of Compassionate Use of a Complex Anti-VEGF Therapy.
    Murray JE; Gold AS; Latiff A; Murray TG
    Clin Ophthalmol; 2021; 15():4731-4738. PubMed ID: 34983996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration.
    Enríquez AB; Baumal CR; Crane AM; Witkin AJ; Lally DR; Liang MC; Enríquez JR; Eichenbaum DA
    JAMA Ophthalmol; 2021 Apr; 139(4):441-448. PubMed ID: 33630045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First Year Real Life Experience With Intravitreal Brolucizumab for Treatment of Refractory Neovascular Age-Related Macular Degeneration.
    Abdin AD; Aljundi W; El Jawhari K; Suffo S; Weinstein I; Seitz B
    Front Pharmacol; 2022; 13():860784. PubMed ID: 35721125
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-term outcomes following treatment of recalcitrant cystoid macular edema secondary to radiation maculopathy using intravitreal brolucizumab.
    Corradetti G; Corvi F; Juhn A; Sadda SR
    Am J Ophthalmol Case Rep; 2020 Dec; 20():100981. PubMed ID: 33145457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal arterial occlusive vasculitis after multiple intravitreal brolucizumab injections for diabetic macular edema.
    Hirano T; Toriyama Y; Takahashi Y; Hoshiyama K; Murata T
    Am J Ophthalmol Case Rep; 2023 Mar; 29():101788. PubMed ID: 36632338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: A real-world case series.
    Chakraborty D; Sheth JU; Boral S; Sinha TK
    Am J Ophthalmol Case Rep; 2021 Dec; 24():101197. PubMed ID: 34504981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab.
    Baumal CR; Spaide RF; Vajzovic L; Freund KB; Walter SD; John V; Rich R; Chaudhry N; Lakhanpal RR; Oellers PR; Leveque TK; Rutledge BK; Chittum M; Bacci T; Enriquez AB; Sund NJ; Subong ENP; Albini TA
    Ophthalmology; 2020 Oct; 127(10):1345-1359. PubMed ID: 32344075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
    Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
    Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal brolucizumab as treatment of early onset radiation retinopathy secondary to plaque brachytherapy for choroidal melanoma.
    Villegas NC; Mishra K; Steinle N; Liu W; Beadle B; Mruthyunjaya P
    Am J Ophthalmol Case Rep; 2022 Sep; 27():101581. PubMed ID: 35599950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal triamcinolone for refractory diabetic macular edema.
    Martidis A; Duker JS; Greenberg PB; Rogers AH; Puliafito CA; Reichel E; Baumal C
    Ophthalmology; 2002 May; 109(5):920-7. PubMed ID: 11986098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.
    Monés J; Srivastava SK; Jaffe GJ; Tadayoni R; Albini TA; Kaiser PK; Holz FG; Korobelnik JF; Kim IK; Pruente C; Murray TG; Heier JS
    Ophthalmology; 2021 Jul; 128(7):1050-1059. PubMed ID: 33207259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab.
    Witkin AJ; Hahn P; Murray TG; Arevalo JF; Blinder KJ; Choudhry N; Emerson GG; Goldberg RA; Kim SJ; Pearlman J; Schneider EW; Tabandeh H; Wong RW
    J Vitreoretin Dis; 2020 Jul; 4(4):269-279. PubMed ID: 32789284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration.
    Avaylon J; Lee S; Gallemore RP
    Int Med Case Rep J; 2020; 13():145-152. PubMed ID: 32494207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced Coats' disease treated with intravitreal brolucizumab combined with laser photocoagulation.
    Patel NA; Berrocal AM; Murray TG; Villegas VM
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100815. PubMed ID: 32671288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration.
    Haug SJ; Hien DL; Uludag G; Ngoc TTT; Lajevardi S; Halim MS; Sepah YJ; Do DV; Khanani AM
    Am J Ophthalmol Case Rep; 2020 Jun; 18():100680. PubMed ID: 32258827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal triamcinolone injection for diabetic macular edema: a clinical and fluorescein angiographic case series.
    Bakri SJ; Beer PM
    Can J Ophthalmol; 2004 Dec; 39(7):755-60. PubMed ID: 15696765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
    Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J
    Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.